Release Date: 23/10/14 09:17 Summary: Non-renouncable Rights Issue to Raise up to $2.2 million Price Sensitive: Yes Download Document 282.81KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market